No abstract available
MeSH terms
-
Androgen Antagonists / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols
-
Docetaxel / therapeutic use
-
Humans
-
Insulin-Like Growth Factor I*
-
Male
-
Prostatic Neoplasms* / drug therapy
-
Prostatic Neoplasms* / pathology
-
Treatment Outcome
Substances
-
Docetaxel
-
Insulin-Like Growth Factor I
-
Androgen Antagonists